We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

670 hedge funds and large institutions have $12.6B invested in United Therapeutics in 2025 Q2 according to their latest regulatory filings, with 77 funds opening new positions, 284 increasing their positions, 218 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 284 | Existing positions reduced: 218

28% more call options, than puts

Call options by funds: $134M | Put options by funds: $105M

8% more first-time investments, than exits

New positions opened: 77 | Existing positions closed: 71

0% less funds holding

Funds holding: 671 → 670 (-1)

2.63% less ownership

Funds ownership: 100.11% → 97.48% (-2.6%)

9% less capital invested

Capital invested by funds: $13.9B → $12.6B (-$1.22B)

10% less funds holding in top 10

Funds holding in top 10: 10 → 9 (-1)

Holders
670
Holders Change
-1
Holders Change %
-0.15%
% of All Funds
8.82%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.12%
New
77
Increased
284
Reduced
218
Closed
71
Calls
$134M
Puts
$105M
Net Calls
+$29M
Net Calls Change
+$30.3M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$125M
2
AQR Capital Management
AQR Capital Management
Connecticut
+$109M
3
DM
Deerfield Management
New York
+$79.3M
4
AssetMark Inc
AssetMark Inc
California
+$59M
5
Victory Capital Management
Victory Capital Management
Texas
+$44.9M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$215M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$174M
3
VNIM
Vaughan Nelson Investment Management
Texas
-$101M
4
ACA
Avoro Capital Advisors
New York
-$91.2M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$47.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
DWM
626
Darwin Wealth Management
Florida
$4.6K – – –
IHWM
627
Iron Horse Wealth Management
Iowa
$4.31K – – –
S
628
Sachetta
Massachusetts
$4.02K +$598 +2 +17%
TWD
629
True Wealth Design
Ohio
$3.74K +$1.49K +5 +63%
DPW
630
DiNuzzo Private Wealth
Pennsylvania
$3.45K +$299 +1 +9%
BFS
631
Bare Financial Services
Pennsylvania
$3.45K +$2.09K +7 +140%
NFSG
632
Newbridge Financial Services Group
Florida
$2.93K +$2.99K +10 New
TFA
633
Toth Financial Advisory
Virginia
$2.87K -$389K -1,300 -99%
MFT
634
Moisand Fitzgerald Tamayo
Florida
$2.59K – – –
PWMG
635
Prestige Wealth Management Group
New Jersey
$2.59K +$299 +1 +13%
NC
636
NewSquare Capital
Pennsylvania
$2.59K +$1.79K +6 +200%
MSFP
637
Mark Sheptoff Financial Planning
Connecticut
$2.3K +$2.39K +8 New
QWM
638
Quaker Wealth Management
New Jersey
$2.3K +$2.39K +8 New
SIC
639
SJS Investment Consulting
Ohio
$1.73K -$897 -3 -33%
EWA
640
EQ Wealth Advisors
Texas
$1.72K -$299 -1 -14%
ZBNA
641
Zions Bancorporation, National Association
Utah
$1.72K – – –
CH
642
Cromwell Holdings
Wyoming
$1.72K +$1.2K +4 +200%
GC
643
Garde Capital
Washington
$1.44K – – –
KWM
644
Kiker Wealth Management
Georgia
$1.44K – – –
WAS
645
Winch Advisory Services
Wisconsin
$1.44K – – –
RWM
646
Rialto Wealth Management
New York
$1.44K +$598 +2 +67%
NEWAS
647
N.E.W. Advisory Services
Wisconsin
$1.15K -$1.2K -4 -50%
CIA
648
Cape Investment Advisory
Georgia
$1.15K – – –
FMP
649
Financial Management Professionals
Texas
$1.15K – – –
AWM
650
Activest Wealth Management
Florida
$1.15K +$1.2K +4 New
24 25
26
27 28

UTHR Hedge Fund Activity: Q2 2025 in Review

670 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2025, worth a combined $12.6B — down 8.8% from $13.9B a quarter earlier.

Buyers outnumbered sellers: 77 funds opened new UTHR positions and 71 closed out — a net gain of 6 holders — while 284 added to existing stakes and 218 trimmed.

The largest buyer was Invesco, adding an estimated $125M. The largest seller was Fidelity Investments, cutting an estimated $215M.

  • 670 institutional investors held United Therapeutics (UTHR) as of Q2 2025, down from 671 in Q1 2025.
  • Funds reported $12.6B of United Therapeutics stock for Q2 2025, down 8.8% quarter-over-quarter.
  • 77 funds opened new United Therapeutics positions in Q2 2025 and 71 closed out, a net change of +6 holders.
  • The largest United Therapeutics buyer in Q2 2025 was Invesco, an estimated $125M added.
  • The largest United Therapeutics seller in Q2 2025 was Fidelity Investments, an estimated $215M sold.

Based on aggregated 13F filings for Q2 2025.